Aila Rissanen

Researcher Next ID · RN-007396

Researcher · Psychology

Helsinki, Finland

Not currently recruitingFunding unknown

Research interests

Psychology

Medicine

Eating Disorders and Behaviors

Obesity, Physical Activity, Diet

Diabetes, Cardiovascular Risks, and Lipoproteins

Adipokines, Inflammation, and Metabolic Diseases

Diet and metabolism studies

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
The Lancet · 2017 · https://doi.org/10.1016/s0140-6736(17)30069-7
Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
The Lancet · 2009 · https://doi.org/10.1016/s0140-6736(09)61375-1
Prediction of Non-Alcoholic Fatty Liver Disease and Liver Fat Using Metabolic and Genetic Factors
Gastroenterology · 2009 · https://doi.org/10.1053/j.gastro.2009.06.005
Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study
The Lancet · 2005 · https://doi.org/10.1016/s0140-6736(05)66374-x
Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients
The Lancet · 1998 · https://doi.org/10.1016/s0140-6736(97)11509-4

No projects listed.